BeStock  
Stocks › Biotechnology › JANX

Janux Therapeutics JANX

US equityMarket cap rank #3470Biotechnology
$10.08 −$0.21 (-2.04%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $10.15 +0.69%
Open$10.11
Prev close$10.29
Day range$10.05 – $10.54
Volume1.11M
Market cap$616.73M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$9.29M-7.1% YoY
Operating profit-$31.26M+11.3% YoY
Net profit-$21.57M+11.3% YoY
Diluted EPS-$0.34+12.8% YoY
Free cash flow-$25.18M-94.5% YoY
Operating cash flow-$25.18M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$10.0MSep '25$0.0Dec '25$3.7MMar '26$10.3MJun '26$9.3MSep '26

Net profit, last 8 quarters

$-20.2MDec '24$-23.5MMar '25$-33.9MJun '25$-24.3MSep '25$-31.9MDec '25$-24.4MMar '26$-22.0MJun '26$-21.6MSep '26

Diluted EPS by quarter

-0.36Dec '24-0.38Mar '25-0.55Jun '25-0.39Sep '25-0.51Dec '25-0.39Mar '26-0.35Jun '26-0.34Sep '26

Free cash flow by quarter

$-16.8MDec '24$-17.4MMar '25$-24.3MJun '25$-12.9MSep '25$-28.6MDec '25$-12.6MMar '26$12.3MJun '26$-25.2MSep '26

Annual revenue

$0.0FY20$3.6MFY21$8.6MFY22$8.1MFY23$10.6MFY24$10.0MFY25

Profitability & balance sheet

Operating margin-599.3%
Net margin-428.7%
Return on equity-10.6%
Return on assets-9.9%
Return on invested capital-14.5%
Current ratio17.69
Liabilities / assets7.3%
Cash & investments$945.72M
Total debt$17.75M
Net cash (debt)$927.97M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $9.29M $10.27M $3.73M $10.00M $0.00
Total Operating Revenue $9.29M $10.27M $3.73M $10.00M $0.00
Operating Expense $40.55M $41.96M $37.95M $167.67M $42.40M
Selling and Admin Expenses $9.98M $10.96M $11.13M $41.77M $10.85M
-General & Admin Expense $9.98M $10.96M $11.13M $41.77M $10.85M
Research & Development $30.57M $30.99M $26.81M $125.90M $31.55M
Operating Profit -$31.26M -$31.69M -$34.21M -$157.67M -$42.40M
Net Non-Operating Interest Income (Expense) $9.69M $9.72M $9.85M $44.04M $10.46M
Non-Operating Interest Income $9.69M $9.72M $9.85M $44.04M $10.46M
Pretax Profit -$21.57M -$21.97M -$24.36M -$113.63M -$31.95M
Net Profit -$21.57M -$21.97M -$24.36M -$113.63M -$31.95M
Profit from Continuing Operations -$21.57M -$21.97M -$24.36M -$113.63M -$31.95M
Net Income to Parent Company -$21.57M -$21.97M -$24.36M -$113.63M -$31.95M
Net Income to Common Stockholders -$21.57M -$21.97M -$24.36M -$113.63M -$31.95M
Basic EPS -$0.34 -$0.35 -$0.39 -$1.83 -$0.51
Diluted EPS -$0.34 -$0.35 -$0.39 -$1.83 -$0.51

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $983.66M $1.01B $1.03B $1.00B $1.00B
Total Current Assets $959.38M $983.34M $1.00B $975.89M $975.89M
Cash and Cash Equivalents & Short-Term Investments $945.72M $970.91M $956.39M $966.57M $966.57M
-Cash and Cash Equivalents $41.82M $27.77M $51.83M $52.33M $52.33M
-Short Term Investments $903.90M $943.15M $904.56M $914.23M $914.23M
Receivables $6.61M $6.33M $42.46M $6.43M $6.43M
-Accounts Receivable $411,000.00 $149,000.00 $35.00M – –
-Accrued Interest Receivable $6.20M $6.18M $7.46M $6.43M $6.43M
Prepaid Assets $7.05M $6.10M $3.20M $2.89M $2.89M
Total Non-Current Assets $24.27M $24.32M $26.18M $25.68M $25.68M
Net PPE $19.57M $20.59M $21.42M $22.25M $22.25M
-Gross PPE $27.79M $28.40M $28.77M $29.22M $29.22M
-Accumulated Depreciation -$8.22M -$7.82M -$7.35M -$6.97M -$6.97M
Other Non-Current Assets $4.71M $3.73M $4.76M $3.42M $3.42M
Total Liabilities $72.04M $79.67M $86.69M $44.74M $44.74M
Total Current Liabilities $54.25M $60.15M $58.92M $25.00M $25.00M
Payables $4.30M $3.02M $3.38M $4.97M $4.97M
-Accounts Payable $4.30M $3.02M $3.38M $4.97M $4.97M
Current Accrued Expenses $15.90M $16.41M $13.23M $13.04M $13.04M
Short-Term Debt and Capital Lease Obligation $2.63M $2.55M $2.47M $2.39M $2.39M
-Current Capital Lease Obligation $2.63M $2.55M $2.47M $2.39M $2.39M
Current Deferred Liabilities $27.22M $35.07M $37.59M – –
Total Non-Current Liabilities $17.80M $19.52M $27.78M $19.75M $19.75M
Long Term Debt and Capital Lease Obligation $17.75M $18.44M $19.10M $19.75M $19.75M
-Long Term Capital Lease Obligation $17.75M $18.44M $19.10M $19.75M $19.75M
Non-Current Deferred Liabilities $50,000.00 $1.08M $8.68M – –
Total Equity $911.61M $927.98M $941.54M $956.82M $956.82M
Stockholders' Equity $911.61M $927.98M $941.54M $956.82M $956.82M
Capital Stock $61,000.00 $61,000.00 $60,000.00 $60,000.00 $60,000.00
-Common Stock $61,000.00 $61,000.00 $60,000.00 $60,000.00 $60,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.34B $1.33B $1.32B $1.30B $1.30B
Retained Earnings -$419.29M -$397.72M -$375.74M -$351.38M -$351.38M
Gains/Losses Not Affecting Retained Earnings -$6.49M -$2.31M $576,000.00 $4.32M $4.32M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$25.18M $12.48M -$12.34M -$82.24M -$28.54M
Net cash flow from continuing operations -$25.18M $12.48M -$12.34M -$82.24M -$28.54M
Net Income from Continuing Operations -$21.57M -$21.97M -$24.36M -$113.63M -$31.95M
Depreciation & Depletion & Amortization $458,000.00 $463,000.00 $469,000.00 $2.03M $468,000.00
Change in Working Capital -$9.28M $27.82M $4.91M $6.71M -$3.06M
-Change in Receivables -$262,000.00 $34.85M -$35.00M – –
-Change in Prepaid Assets -$979,000.00 -$1.61M -$1.34M -$827,000.00 -$227,000.00
-Change in Payables and Accrued Expense $1.87M $3.70M -$3.64M $7.27M -$2.85M
-Change in Other Current Assets -$977,000.00 $1.03M -$1.34M $276,000.00 $19,000.00
-Change In Other Working Capital -$8.93M -$10.16M $46.23M -$2,000.00 $0.00
Net cash flow from investing $38.38M -$38.78M $8.29M -$300.98M $29.54M
Net Cash Flow from Continuing Investing Activities $38.38M -$38.78M $8.29M -$300.98M $29.54M
Net PPE Purchase and Sale -$2,000.00 -$202,000.00 -$273,000.00 -$1.04M -$106,000.00
Net Investment Purchase and Sale $38.38M -$38.58M $8.56M -$299.94M $29.65M
Financing Cash Flow $852,000.00 $2.24M $3.55M $4.95M $2.94M
Net Cash Flow from Continuing Financing Activities $852,000.00 $2.24M $3.55M $4.95M $2.94M
Net Common Stock Issuance $0.00 $0.00 $0.00 -$347,000.00 $0.00
Proceeds from Stock Option Exercised $852,000.00 $2.24M $3.55M $5.29M $2.94M
Ending Cash Balance $42.63M $28.58M $52.64M $53.15M $53.15M
Net Change in Cash $14.05M -$24.06M -$506,000.00 -$378.27M $3.95M
Beginning Cash Balance $28.58M $52.64M $53.15M $431.42M $49.21M
Free Cash Flow -$25.18M $12.28M -$12.61M -$83.28M -$28.65M

Discussion

No comments yet — be the first to weigh in on JANX.

Sign in to join the discussion.

Scroll to Top